Beining Guo
Overview
Explore the profile of Beining Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu H, Li Y, Li X, Fan Y, Guo B, Liu X, et al.
Front Pharmacol
. 2025 Mar;
16:1476158.
PMID: 40028165
Introduction: The establishment of clinical breakpoints for antimicrobial drug is crucial for guiding appropriate therapeutic interventions. This study aims to identify the pharmacokinetic/pharmacodynamic (PK/PD) cut-offs for using sitafloxacin against target...
2.
Huang Z, Li W, Zhang R, Li Y, Li X, Bian X, et al.
Front Microbiol
. 2025 Jan;
15:1516979.
PMID: 39741587
Introduction: Pralurbactam (FL058) is a novel β-lactamase inhibitor with good inhibitory activity on class A, C, and D β-lactamases. This study aimed to evaluate the pharmacokinetic/pharmacodynamic (PK/PD) relationship of pralurbactam/meropenem...
3.
Wang Y, Liu X, Chen Y, Guo B, Liu J, Zhang J
J Chromatogr B Analyt Technol Biomed Life Sci
. 2024 Oct;
1247:124332.
PMID: 39423560
Pulmonary epithelial lining fluid (ELF) was commonly used for the pharmacokinetic study in lower respiratory tract infections. To characterize the intrapulmonary pharmacokinetic properties of polymyxin B following aerosol delivery, we...
4.
Wang B, Wang L, Guo B, Kong Y, Wang F, Jing Z, et al.
Adv Mater
. 2024 Oct;
36(48):e2411725.
PMID: 39410861
Room temperature sodium-sulfur batteries (RT Na-S) have garnered significant attention for their high energy density and cost-effectiveness, positioning them as a promising alternative to lithium-ion batteries. However, they encounter challenges...
5.
Huang X, Liu X, Fan Y, Wang Y, Guo B, Wang J, et al.
Int J Antimicrob Agents
. 2024 Sep;
64(5):107326.
PMID: 39276945
Objective: Increasing antimicrobial resistance has led to the revival of the polymyxins as a last-resort therapeutic option for multidrug-resistant Gram-negative bacterial infections. A parenteral formulation of colistin sulfate is available...
6.
Xi L, Li S, Chen M, Huang X, Li N, Chen N, et al.
Antibiotics (Basel)
. 2024 Apr;
13(4).
PMID: 38667000
Elderly patients (age ≥ 65 years) are susceptible to methicillin-resistant (MRSA) infections, with potential for more adverse treatment outcomes or complications compared to younger adults (18-64 years). This study compared...
7.
Huang Z, Bian X, Li Y, Hu J, Guo B, Yang X, et al.
Front Pharmacol
. 2024 Apr;
15:1282480.
PMID: 38666023
FL058 is a novel beta-lactamase inhibitor with a broad spectrum of activity and a favorable safety profile. The objective of this study was to evaluate pharmacokinetic/pharmacodynamic (PK/PD) relationships for the...
8.
Fan Y, Zhang K, Chen M, Li N, Liu X, Yang M, et al.
mSphere
. 2023 Oct;
8(6):e0045723.
PMID: 37905831
Methicillin-resistant (MRSA) is a bacterium that is resistant to multiple drugs and can cause serious infections. In recent years, one of the most widespread strains of MRSA worldwide has been...
9.
Li Y, Zhan H, Wu J, Yu J, Cao G, Wu X, et al.
Eur J Pharm Biopharm
. 2023 May;
188:153-160.
PMID: 37142130
Phospholipid-valproic acid (DP-VPA)is a prodrug for treating epilepsy. The present study explored the pharmacokinetics (PK) and exposure safety of DP-VPA to provide a basis for future studies exploring the safe...
10.
Chen Y, Wu X, Tsai C, Chang L, Yu J, Cao G, et al.
Front Pharmacol
. 2023 Mar;
14:912962.
PMID: 36923351
Nemonoxacin is an innovative quinolone antibiotic for treatment of community-acquired pneumonia (CAP). As more data are available from clinical studies, it is necessary to perform an integrative pharmacokinetic/pharmacodynamic (PK/PD) analysis...